IntelGenx Technologies Corp. enters into consulting agreement with Dr. David Coffin-Beach

January 30, 2007

Saint Laurent, Quebec-(CCNMatthews – January 30, 2007) - IntelGenx Technologies Corporation (OTCBB:IGXT)("IntelGenx" or the "Company") is pleased to announce that it has entered into a consulting agreement with Dr. David Coffin-Beach. He currently acts as the President of ATP Solutions, Inc. As the former President and CEO of TorPharm and Associate Director at Schering Plough, Dr. Coffin-Beach brings a wealth of experience in the pharmaceutical industry to the table. In this consultative role, his major functions will be to provide strategic guidance, participate in the company’s fundraising efforts, represent the company in discussions with potential investors, and provide counsel as required to promote the growth of the company.

"We are very pleased to have Dr. Coffin-Beach join Intelgenx as an advisor to its executive team. Dr Coffin-Beach brings to Intelgenx  vast and in depth management experience acquired at the highest level in major pharmaceutical companies. He will play a key role in our business and corporate development as more of our drugs progress into advanced development stages" said Dr. Horst Zerbe, President and CEO of Intelgenx Technologies Corp.

IntelGenx Corp. is a drug delivery company focused on the development of oral controlled-release products as well as novel rapidly disintegrating delivery systems. The company uses its unique multiple layer delivery system to provide zero-order release of active drugs in the gastro-intestinal tract. IntelGenx has also developed novel delivery technologies for the rapid delivery of pharmaceutically active substances in the oral cavity based on its experience with rapidly disintegrating films.  The company’s research and development pipeline includes products for the treatment of osteoarthritis, pain management, smoking cessation, and seasonal affective disorder.



Dr. Horst G. Zerbe, President and CEO


IntelGenx Corp
Horst Zerbe, Ph.D.
President and CEO
T: 514-331-7440 (ext. 201)
F: 514-331-0436


Jelf Caruso
Auctus Capital Partners
Investor Relations

The OTCBB has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.